Fig. 2

Kaplan–Meier overall survival (OS) curves for the LSCC cohort studied (n = 80). A significantly shorter 5-year OS rate was observed for patients with LSCC characterized by low levels of miR-101 expression (47.5 %; n = 40; lower curve) compared with LSCC patients with high levels of miR-101 (67.5 % %; n = 40; upper curve) (P = 0.047).